Skip to content

BL, 04.1 MM RC, SLACTIVE 8MM, TIZR AND 10MM, 12, 14MM SLActive Roxolid BL (REF 021.6308)Recalls & reported problems

Institut Straumann AG · Bone Level Implant D 4.8mm RC, SLActive® 8mm, Roxolid® Loxim™ · Class 2 · Implant

All models of BL, 04.1 MM RC, SLACTIVE 8MM, TIZR AND 10MM, 12, 14MM (14)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Quick summary

This Straumann Bone Level implant is placed in the jawbone. The reports mostly describe implants that did not bond with the bone, with some also mentioning pain, infection or tissue damage. FDA records list 5,327 reports, no deaths, 5,327 injuries and no malfunction reports. No recalls name this device.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
5,337
Deaths reported
0
Injuries reported
5,337
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5,337 adverse event reports that list this exact device (DI 07630031707246), received between Sep 9, 2019 and Sep 28, 2026 — classified as 5,337 injuries.

The most frequently reported specific device problem is “Failure to Osseointegrate” (3,423 reports).

1 other recall cover devices cleared under the same FDA submission (K121131); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 77 reportsDec 2023: 85 reportsJan 2024: 75 reportsFeb 2024: 67 reportsMar 2024: 79 reportsApr 2024: 83 reportsMay 2024: 48 reportsJun 2024: 58 reportsJul 2024: 68 reportsAug 2024: 50 reportsSep 2024: 95 reportsOct 2024: 74 reportsNov 2024: 76 reportsDec 2024: 56 reportsJan 2025: 46 reportsFeb 2025: 48 reportsMar 2025: 78 reportsApr 2025: 12 reportsMay 2025: 0 reportsJun 2025: 168 reportsJul 2025: 75 reportsAug 2025: 81 reportsSep 2025: 42 reportsOct 2025: 44 reportsNov 2025: 65 reportsDec 2025: 54 reportsJan 2026: 44 reportsFeb 2026: 62 reportsMar 2026: 53 reportsApr 2026: 57 reportsMay 2026: 56 reportsJun 2026: 54 reportsJul 2026: 50 reportsAug 2026: 44 reportsSep 2026: 26 reportsOct 2026: 0 reports202420252026168
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Osseointegrate3,423
  • Loss of Osseointegration1,480
  • Adverse Event Without Identified Device or Use Problem379
  • Difficult to Insert48
  • Fracture17
  • Separation Failure8
  • Unstable5
  • Therapeutic or Diagnostic Output Failure4

Patient problems

  • No Clinical Signs, Symptoms or Conditions2,262
  • Fibrosis1,594
  • Pain970
  • Unspecified Infection668
  • Tissue Damage614
  • Inflammation382
  • Hemorrhage/Blood Loss/Bleeding263
  • Swelling/ Edema181

Recent adverse event reports

The 25 most recent of 5,337 reports, in the reporter's own words as published by the FDA.

  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Swelling/ Edema

    MAUDE report 50919849 ↗
  • InjurySep 17, 2026Failure to Osseointegrate

    Patient problems: Inflammation

    MAUDE report 50807408 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50759678 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50759564 ↗
  • InjurySep 14, 2026Loss of Osseointegration

    Patient problems: Fibrosis; Hemorrhage/Blood Loss/Bleeding; Inflammation

    MAUDE report 50759562 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6)2026 in the patient's mouth. Details of surgery: Primary stability not achieved. On (b)(6)2026 non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50758872 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Pain

    MAUDE report 50758347 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50757717 ↗
  • InjurySep 14, 2026Loss of Osseointegration

    Patient problems: Fibrosis; Hemorrhage/Blood Loss/Bleeding; Inflammation

    MAUDE report 50757619 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2025 in ADA 19. On (b)(6) 2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50757615 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in ADA 2. On (b)(6) 2026, non-osseointegration was verified. Patient presented with inadequate bone quality/quantity. The device was forwarded to the manufacturer. At the event the patient experienced: Pain and Mobility. No further patient complications were reported.

    Patient problems: Fibrosis; Pain

    MAUDE report 50757564 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Inflammation; Swelling/ Edema

    MAUDE report 50720113 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Inflammation; Swelling/ Edema

    MAUDE report 50720112 ↗
  • InjurySep 10, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Pain

    MAUDE report 50719564 ↗
  • InjurySep 10, 2026Loss of Osseointegration

    Patient problems: Fibrosis

    MAUDE report 50719446 ↗
  • InjurySep 10, 2026Loss of Osseointegration

    Patient problems: Fibrosis

    MAUDE report 50719177 ↗
  • InjurySep 10, 2026Loss of Osseointegration

    The clinician reports the implant was inserted 2021 (b)(6) in ADA 14. On 2026 (b)(6), loss of osseointegration was verified. The device was forwarded to the manufacturer. At the event the patient experienced: Mobility. No further patient complications were reported.

    Patient problems: Fibrosis

    MAUDE report 50718692 ↗
  • InjurySep 7, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50654710 ↗
  • InjurySep 7, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50654694 ↗
  • InjurySep 7, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50654556 ↗
  • InjurySep 7, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50654553 ↗
  • InjurySep 7, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50654280 ↗
  • InjurySep 7, 2026Failure to Osseointegrate

    Patient problems: Abscess; Fibrosis; Unspecified Infection

    MAUDE report 50654259 ↗
  • InjurySep 7, 2026Loss of Osseointegration

    Patient problems: Fibrosis; Unspecified Infection

    MAUDE report 50653951 ↗
  • InjurySep 7, 2026Adverse Event Without Identified Device or Use Problem

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50653495 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K121131. One submission often covers many models, so check the product and lot details in each record.

  • Z-0174-2015 · Sep 24, 2014 · Terminated
    Straumann Bone Level Implant 04.1 mm RC, SLActive 8mm, Roxolid, Loxim Article Number: 021.4308 Product Usage: Dental implants are intended for surgical placement in maxillary and/

Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices

All IMPLANT, ENDOSSEOUS, ROOT-FORM devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page